Literature DB >> 16788009

Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting.

Y Mineharu1, K Takenaka, H Yamakawa, K Inoue, H Ikeda, K-I Kikuta, Y Takagi, K Nozaki, N Hashimoto, A Koizumi.   

Abstract

BACKGROUND: Although the aetiology of moyamoya disease (MMD) has not been fully clarified, genetic analysis of familial MMD (F-MMD) has considerable potential to disclose it.
OBJECTIVE: To determine the inheritance pattern and clinical characteristics of F-MMD to enable precise genetic analyses of the disease.
METHODS: 15 highly aggregated Japanese families (52 patients; 38 women and 14 men) with three or more affected members were examined. The difference in categories of age at onset (child onset, adult onset and asymptomatic) between paternal and maternal transmission was compared by chi2 statistics.
RESULTS: In all families there had been three or more generations without consanguinity, and all types of transmission, including father-to-son, were observed. Among a total of 135 offspring of affected people, 59 (43.7%) were patients with MMD or obligatory carriers. Affected mothers were more likely to produce late-onset (adult-onset or asymptomatic) female offspring (p = 0.007).
CONCLUSIONS: The mode of inheritance of F-MMD is autosomal dominant with incomplete penetrance. Thus, in future genetic studies on F-MMD, parametric linkage analyses using large families with an autosomal dominant mode of inheritance are recommended. Genomic imprinting may be associated with the disease.

Entities:  

Mesh:

Year:  2006        PMID: 16788009      PMCID: PMC2077755          DOI: 10.1136/jnnp.2006.096040

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  29 in total

Review 1.  [Familial moyamoya disease--clinical features and current study].

Authors:  Rina Nanba; Satoshi Kuroda; Tatsuya Ishikawa; Yoshinobu Iwasaki; Mitsuhiro Tada; Houkin Kiyohiro
Journal:  No Shinkei Geka       Date:  2004-01

2.  [Moyamoya disease in fraternal twins].

Authors:  N Asami; S Miyahara; T Ueda; S Wakisaka; K Kinoshita
Journal:  No To Shinkei       Date:  1990-11

3.  ["Moyamoya" disease found in identical twins (author's transl)].

Authors:  M Sonobe; S Takahashi; Y Urakawa; Y Nagamine; N Kodama; H Fukazawa
Journal:  No Shinkei Geka       Date:  1980-12

4.  Discordant KCNQ1OT1 imprinting in sets of monozygotic twins discordant for Beckwith-Wiedemann syndrome.

Authors:  Rosanna Weksberg; Cheryl Shuman; Oana Caluseriu; Adam C Smith; Yan-Ling Fei; Joy Nishikawa; Tracy L Stockley; Lyle Best; David Chitayat; Ann Olney; Elizabeth Ives; Adele Schneider; Timothy H Bestor; Madeline Li; Paul Sadowski; Jeremy Squire
Journal:  Hum Mol Genet       Date:  2002-05-15       Impact factor: 6.150

5.  Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25.

Authors:  T Yamauchi; M Tada; K Houkin; T Tanaka; Y Nakamura; S Kuroda; H Abe; T Inoue; K Ikezaki; T Matsushima; M Fukui
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

6.  Moyamoya disease in monovular twins: case report.

Authors:  H Yamada; S Nakamura; N Kageyama
Journal:  J Neurosurg       Date:  1980-07       Impact factor: 5.115

7.  Familial association of basilar bifurcation aneurysm and moyamoya disease--four case reports.

Authors:  Hiroyoshi Akutsu; Makoto Sonobe; Kyoichi Sugita; Yasunobu Nakai; Akira Matsumura
Journal:  Neurol Med Chir (Tokyo)       Date:  2003-09       Impact factor: 1.742

8.  [Adult identical twins with moyamoya disease].

Authors:  M Kashihara; H Oki; K Sasaki; T Soga; S Ueda; K Matsumoto
Journal:  No Shinkei Geka       Date:  1984-11

9.  A novel susceptibility locus for moyamoya disease on chromosome 8q23.

Authors:  Kaoru Sakurai; Yasue Horiuchi; Hidetoshi Ikeda; Kiyonobu Ikezaki; Takashi Yoshimoto; Masashi Fukui; Tadao Arinami
Journal:  J Hum Genet       Date:  2004       Impact factor: 3.172

10.  [Moyamoya disease in twins].

Authors:  S Kawamura; H Hadeishi; A Suzuki; N Yasui
Journal:  No To Shinkei       Date:  1987-02
View more
  31 in total

1.  Familial moyamoya disease in two Turkish siblings with same polymorphism in RNF213 gene but different clinical features.

Authors:  Ayşe Kaçar Bayram; Ebru Yilmaz; Huseyin Per; Masaki Ito; Haruto Uchino; Selim Doganay; Kiyohiro Houkin; Ekrem Unal
Journal:  Childs Nerv Syst       Date:  2015-08-16       Impact factor: 1.475

2.  Rare RNF213 variants in the C-terminal region encompassing the RING-finger domain are associated with moyamoya angiopathy in Caucasians.

Authors:  Stéphanie Guey; Markus Kraemer; Dominique Hervé; Thomas Ludwig; Manoëlle Kossorotoff; Françoise Bergametti; Jan Claudius Schwitalla; Simone Choi; Lucile Broseus; Isabelle Callebaut; Emmanuelle Genin; Elisabeth Tournier-Lasserve
Journal:  Eur J Hum Genet       Date:  2017-06-21       Impact factor: 4.246

3.  A rare Asian founder polymorphism of Raptor may explain the high prevalence of Moyamoya disease among East Asians and its low prevalence among Caucasians.

Authors:  Wanyang Liu; Hirokuni Hashikata; Kayoko Inoue; Norio Matsuura; Yohei Mineharu; Hatasu Kobayashi; Ken-Ichiro Kikuta; Yasushi Takagi; Toshiaki Hitomi; Boris Krischek; Li-Ping Zou; Fang Fang; Roman Herzig; Jeong-Eun Kim; Hyun-Seung Kang; Chang-Wan Oh; David-Alexandre Tregouet; Nobuo Hashimoto; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2009-11-19       Impact factor: 3.674

4.  P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure.

Authors:  Akio Koizumi; Hatasu Kobayashi; Wanyang Liu; Yukiko Fujii; S T M L D Senevirathna; Shanika Nanayakkara; Hiroko Okuda; Toshiaki Hitomi; Kouji H Harada; Katsunobu Takenaka; Takao Watanabe; Shinichiro Shimbo
Journal:  Environ Health Prev Med       Date:  2012-08-10       Impact factor: 3.674

Review 5.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

6.  RNF213 rare variants in an ethnically diverse population with Moyamoya disease.

Authors:  Alana C Cecchi; Dongchuan Guo; Zhao Ren; Kelly Flynn; Regie Lyn P Santos-Cortez; Suzanne M Leal; Gao T Wang; Ellen S Regalado; Gary K Steinberg; Jay Shendure; Michael J Bamshad; James C Grotta; Deborah A Nickerson; Hariyadarshi Pannu; Dianna M Milewicz
Journal:  Stroke       Date:  2014-10-02       Impact factor: 7.914

7.  Pediatric and newborn stroke.

Authors:  Sharon Goodman; Steven Pavlakis
Journal:  Curr Treat Options Neurol       Date:  2008-11       Impact factor: 3.598

Review 8.  The role of genetics in stroke.

Authors:  John Francis; Senthil Raghunathan; Pradeep Khanna
Journal:  Postgrad Med J       Date:  2007-09       Impact factor: 2.401

9.  Identification of novel biomarker candidates by proteomic analysis of cerebrospinal fluid from patients with moyamoya disease using SELDI-TOF-MS.

Authors:  Yoshio Araki; Kazuhiro Yoshikawa; Sho Okamoto; Masaki Sumitomo; Mikio Maruwaka; Toshihiko Wakabayashi
Journal:  BMC Neurol       Date:  2010-11-08       Impact factor: 2.474

10.  Disrupted nitric oxide signaling due to GUCY1A3 mutations increases risk for moyamoya disease, achalasia and hypertension.

Authors:  S Wallace; D-C Guo; E Regalado; L Mellor-Crummey; M Bamshad; D A Nickerson; R Dauser; N Hanchard; R Marom; E Martin; V Berka; I Sharina; V Ganesan; D Saunders; S A Morris; D M Milewicz
Journal:  Clin Genet       Date:  2016-02-18       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.